Jiangsu Hengrui Pharmaceuticals Co Ltd
Jiangsu Hengrui Pharmaceuticals's GHG Emissions Data Preview
In 2023, Jiangsu Hengrui Pharmaceuticals completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Jiangsu Hengrui Pharmaceuticals has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Jiangsu Hengrui Pharmaceuticals's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Jiangsu Hengrui Pharmaceuticals amounted to 208,280.08 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Jiangsu Hengrui Pharmaceuticals increased by 2.34%, suggesting that the company faced challenges in reducing its emissions from its core operations.
Jiangsu Hengrui Pharmaceuticals's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Jiangsu Hengrui Pharmaceuticals's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Jiangsu Hengrui Pharmaceuticals were 4,898 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Jiangsu Hengrui Pharmaceuticals reduced its Scope 1 emissions over time?
Since 2021, Jiangsu Hengrui Pharmaceuticals's Scope 1 emissions have decreased by 44.58%, reflecting a declining long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), Jiangsu Hengrui Pharmaceuticals's Scope 1 emissions decreased by 18.28%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
What are Jiangsu Hengrui Pharmaceuticals's Scope 2 emissions?
In 2023, Jiangsu Hengrui Pharmaceuticals reported Scope 2 greenhouse gas (GHG) emissions of 203,382.08 tCOâ‚‚e without specifying the calculation method.
Has Jiangsu Hengrui Pharmaceuticals reduced its Scope 2 emissions over time?
Since 2021, Jiangsu Hengrui Pharmaceuticals's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have decreased by 13.54%, reflecting a declining long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), Jiangsu Hengrui Pharmaceuticals's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Jiangsu Hengrui Pharmaceuticals 's emissions have plateaued with no significant change in its energy consumption footprint.
What methodology does Jiangsu Hengrui Pharmaceuticals use for Scope 2 reporting?
In 2023, Jiangsu Hengrui Pharmaceuticals reported its Scope 2 emissions using an unspecified methodology.
Jiangsu Hengrui Pharmaceuticals's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)